Used in cancer treatment, particularly in clinical trials for soft tissue sarcomas. Acts as an active metabolite of ifosfamide, designed to directly deliver the cytotoxic effect without requiring liver metabolism. This allows for more targeted chemotherapy with potentially reduced side effects compared to ifosfamide. Investigated for its ability to alkylate DNA, leading to cancer cell death. Development aimed at improving therapeutic efficacy and safety in solid tumors.